Pfizer Inc. PFE

28.67 0.26 0.92% as of 25 Sep
Market cap
$161.7B
P/E
37.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Pfizer Inc. (PFE) P/E ratio

As of 25 September 2026, Pfizer Inc. (PFE) trades at a P/E ratio of 37.7×. Over the past ten years it has ranged from 0.0× (September 2024) to 82.6× (January 2024); the current reading is higher than 97% of that period. That is above the Drug Manufacturers General industry median of 24.7× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 18.3× (2.11%)
FY2024 18.7× (77.35%)
FY2023 82.6× 797.36%
FY2022 9.2× (39.22%)
FY2021 15.1× (29.25%)
FY2020 21.4× 67.55%
FY2019 12.8× (42.01%)
FY2018 22.0× 127.47%
FY2017 9.7× (63.81%)
FY2016 26.8× 10.08%

Quarterly

Period P/E ratio Change
Jun 2026 31.7× 47.81%
Mar 2026 21.4× 17.08%
Dec 2025 18.3× 23.59%
Sep 2025 14.8× 15.51%
42 more quarters

Against its own ten years

Low 0.0× High 82.6×
Ten-year median 18.3×
Current reading's percentile 97

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
BMY Bristol Myers Squibb Company compare 13.8×
GSK GSK PLC Sponsored ADR compare 15.3×
SNY Sanofi compare 21.5×
NVS Novartis AG compare 21.8×
AZN AstraZeneca PLC compare 24.7×
AMGN Amgen Inc. compare 25.6×
PFE Pfizer Inc. 37.7×
Drug Manufacturers General industry median 24.7×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PFE